The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preventive Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Preventive Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preventive Vaccines market size is estimated to be worth US$ 56140 million in 2021 and is forecast to a readjusted size of USD 97530 million by 2028 with a CAGR of 8.2% during review period. Hospital accounting for % of the Preventive Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intramuscular Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preventive Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Preventive Vaccines market are listed below:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preventive Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Preventive Vaccines, with price, sales, revenue and global market share of Preventive Vaccines from 2019 to 2022.
Chapter 3, the Preventive Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preventive Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Preventive Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preventive Vaccines.
Chapter 13, 14, and 15, to describe Preventive Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Preventive Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preventive Vaccines market size is estimated to be worth US$ 56140 million in 2021 and is forecast to a readjusted size of USD 97530 million by 2028 with a CAGR of 8.2% during review period. Hospital accounting for % of the Preventive Vaccines global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intramuscular Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preventive Vaccines market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intramuscular Injection
Nasal Spray
Intradermal Shot
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Preventive Vaccines market are listed below:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Preventive Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Preventive Vaccines, with price, sales, revenue and global market share of Preventive Vaccines from 2019 to 2022.
Chapter 3, the Preventive Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Preventive Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Preventive Vaccines market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Preventive Vaccines.
Chapter 13, 14, and 15, to describe Preventive Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Preventive Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Preventive Vaccines Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intramuscular Injection
1.2.3 Nasal Spray
1.2.4 Intradermal Shot
1.3 Market Analysis by Application
1.3.1 Overview: Global Preventive Vaccines Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Preventive Vaccines Market Size & Forecast
1.4.1 Global Preventive Vaccines Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Preventive Vaccines Sales in Volume (2017-2028)
1.4.3 Global Preventive Vaccines Price (2017-2028)
1.5 Global Preventive Vaccines Production Capacity Analysis
1.5.1 Global Preventive Vaccines Total Production Capacity (2017-2028)
1.5.2 Global Preventive Vaccines Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Preventive Vaccines Market Drivers
1.6.2 Preventive Vaccines Market Restraints
1.6.3 Preventive Vaccines Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Preventive Vaccines Product and Services
2.1.4 Sanofi Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Preventive Vaccines Product and Services
2.2.4 AstraZeneca Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CSL Ltd
2.3.1 CSL Ltd Details
2.3.2 CSL Ltd Major Business
2.3.3 CSL Ltd Preventive Vaccines Product and Services
2.3.4 CSL Ltd Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Preventive Vaccines Product and Services
2.4.4 Abbott Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Preventive Vaccines Product and Services
2.5.4 GlaxoSmithKline Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Preventive Vaccines Product and Services
2.6.4 Serum Institute of India Preventive Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Preventive Vaccines Breakdown Data by Manufacturer
3.1 Global Preventive Vaccines Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Preventive Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Preventive Vaccines
3.4 Market Concentration Rate
3.4.1 Top 3 Preventive Vaccines Manufacturer Market Share in 2021
3.4.2 Top 6 Preventive Vaccines Manufacturer Market Share in 2021
3.5 Global Preventive Vaccines Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Preventive Vaccines Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Preventive Vaccines Market Size by Region
4.1.1 Global Preventive Vaccines Sales in Volume by Region (2017-2028)
4.1.2 Global Preventive Vaccines Revenue by Region (2017-2028)
4.2 North America Preventive Vaccines Revenue (2017-2028)
4.3 Europe Preventive Vaccines Revenue (2017-2028)
4.4 Asia-Pacific Preventive Vaccines Revenue (2017-2028)
4.5 South America Preventive Vaccines Revenue (2017-2028)
4.6 Middle East and Africa Preventive Vaccines Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Preventive Vaccines Sales in Volume by Type (2017-2028)
5.2 Global Preventive Vaccines Revenue by Type (2017-2028)
5.3 Global Preventive Vaccines Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Preventive Vaccines Sales in Volume by Application (2017-2028)
6.2 Global Preventive Vaccines Revenue by Application (2017-2028)
6.3 Global Preventive Vaccines Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Preventive Vaccines Sales by Type (2017-2028)
7.2 North America Preventive Vaccines Sales by Application (2017-2028)
7.3 North America Preventive Vaccines Market Size by Country
7.3.1 North America Preventive Vaccines Sales in Volume by Country (2017-2028)
7.3.2 North America Preventive Vaccines Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Preventive Vaccines Sales by Type (2017-2028)
8.2 Europe Preventive Vaccines Sales by Application (2017-2028)
8.3 Europe Preventive Vaccines Market Size by Country
8.3.1 Europe Preventive Vaccines Sales in Volume by Country (2017-2028)
8.3.2 Europe Preventive Vaccines Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Preventive Vaccines Sales by Type (2017-2028)
9.2 Asia-Pacific Preventive Vaccines Sales by Application (2017-2028)
9.3 Asia-Pacific Preventive Vaccines Market Size by Region
9.3.1 Asia-Pacific Preventive Vaccines Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Preventive Vaccines Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Preventive Vaccines Sales by Type (2017-2028)
10.2 South America Preventive Vaccines Sales by Application (2017-2028)
10.3 South America Preventive Vaccines Market Size by Country
10.3.1 South America Preventive Vaccines Sales in Volume by Country (2017-2028)
10.3.2 South America Preventive Vaccines Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Preventive Vaccines Sales by Type (2017-2028)
11.2 Middle East & Africa Preventive Vaccines Sales by Application (2017-2028)
11.3 Middle East & Africa Preventive Vaccines Market Size by Country
11.3.1 Middle East & Africa Preventive Vaccines Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Preventive Vaccines Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Preventive Vaccines and Key Manufacturers
12.2 Manufacturing Costs Percentage of Preventive Vaccines
12.3 Preventive Vaccines Production Process
12.4 Preventive Vaccines Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Preventive Vaccines Typical Distributors
13.3 Preventive Vaccines Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Preventive Vaccines Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Preventive Vaccines Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Preventive Vaccines Product and Services
Table 6. Sanofi Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 8. AstraZeneca Major Business
Table 9. AstraZeneca Preventive Vaccines Product and Services
Table 10. AstraZeneca Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 12. CSL Ltd Major Business
Table 13. CSL Ltd Preventive Vaccines Product and Services
Table 14. CSL Ltd Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Abbott Basic Information, Manufacturing Base and Competitors
Table 16. Abbott Major Business
Table 17. Abbott Preventive Vaccines Product and Services
Table 18. Abbott Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Major Business
Table 21. GlaxoSmithKline Preventive Vaccines Product and Services
Table 22. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Preventive Vaccines Product and Services
Table 26. Serum Institute of India Preventive Vaccines Sales (K Doses), Price (USD/Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Preventive Vaccines Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 28. Global Preventive Vaccines Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Preventive Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Preventive Vaccines Production Capacity by Company, (K Doses): 2020 VS 2021
Table 31. Head Office and Preventive Vaccines Production Site of Key Manufacturer
Table 32. Preventive Vaccines New Entrant and Capacity Expansion Plans
Table 33. Preventive Vaccines Mergers & Acquisitions in the Past Five Years
Table 34. Global Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
Table 35. Global Preventive Vaccines Sales by Region (2023-2028) & (K Doses)
Table 36. Global Preventive Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Preventive Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 39. Global Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 40. Global Preventive Vaccines Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Preventive Vaccines Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Preventive Vaccines Price by Type (2017-2022) & (USD/Doses)
Table 43. Global Preventive Vaccines Price by Type (2023-2028) & (USD/Doses)
Table 44. Global Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 45. Global Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 46. Global Preventive Vaccines Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Preventive Vaccines Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Preventive Vaccines Price by Application (2017-2022) & (USD/Doses)
Table 49. Global Preventive Vaccines Price by Application (2023-2028) & (USD/Doses)
Table 50. North America Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 51. North America Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
Table 52. North America Preventive Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Preventive Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 55. North America Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 56. North America Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 57. North America Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 58. Europe Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 59. Europe Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
Table 60. Europe Preventive Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Preventive Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 63. Europe Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 64. Europe Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 65. Europe Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 66. Asia-Pacific Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
Table 67. Asia-Pacific Preventive Vaccines Sales by Region (2023-2028) & (K Doses)
Table 68. Asia-Pacific Preventive Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Preventive Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 71. Asia-Pacific Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 72. Asia-Pacific Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 73. Asia-Pacific Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 74. South America Preventive Vaccines Sales by Country (2017-2022) & (K Doses)
Table 75. South America Preventive Vaccines Sales by Country (2023-2028) & (K Doses)
Table 76. South America Preventive Vaccines Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Preventive Vaccines Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 79. South America Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 80. South America Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 81. South America Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 82. Middle East & Africa Preventive Vaccines Sales by Region (2017-2022) & (K Doses)
Table 83. Middle East & Africa Preventive Vaccines Sales by Region (2023-2028) & (K Doses)
Table 84. Middle East & Africa Preventive Vaccines Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Preventive Vaccines Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Preventive Vaccines Sales by Type (2017-2022) & (K Doses)
Table 87. Middle East & Africa Preventive Vaccines Sales by Type (2023-2028) & (K Doses)
Table 88. Middle East & Africa Preventive Vaccines Sales by Application (2017-2022) & (K Doses)
Table 89. Middle East & Africa Preventive Vaccines Sales by Application (2023-2028) & (K Doses)
Table 90. Preventive Vaccines Raw Material
Table 91. Key Manufacturers of Preventive Vaccines Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Preventive Vaccines Typical Distributors
Table 95. Preventive Vaccines Typical Customers
List of Figures
Figure 1. Preventive Vaccines Picture
Figure 2. Global Preventive Vaccines Revenue Market Share by Type in 2021
Figure 3. Intramuscular Injection
Figure 4. Nasal Spray
Figure 5. Intradermal Shot
Figure 6. Global Preventive Vaccines Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Preventive Vaccines Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Preventive Vaccines Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Preventive Vaccines Sales (2017-2028) & (K Doses)
Figure 13. Global Preventive Vaccines Price (2017-2028) & (USD/Doses)
Figure 14. Global Preventive Vaccines Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Preventive Vaccines Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Preventive Vaccines Market Drivers
Figure 17. Preventive Vaccines Market Restraints
Figure 18. Preventive Vaccines Market Trends
Figure 19. Global Preventive Vaccines Sales Market Share by Manufacturer in 2021
Figure 20. Global Preventive Vaccines Revenue Market Share by Manufacturer in 2021
Figure 21. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Preventive Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Preventive Vaccines Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Preventive Vaccines Sales Market Share by Region (2017-2028)
Figure 25. Global Preventive Vaccines Revenue Market Share by Region (2017-2028)
Figure 26. North America Preventive Vaccines Revenue (2017-2028) & (USD Million)
Figure 27. Europe Preventive Vaccines Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Preventive Vaccines Revenue (2017-2028) & (USD Million)
Figure 29. South America Preventive Vaccines Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Preventive Vaccines Revenue (2017-2028) & (USD Million)
Figure 31. Global Preventive Vaccines Sales Market Share by Type (2017-2028)
Figure 32. Global Preventive Vaccines Revenue Market Share by Type (2017-2028)
Figure 33. Global Preventive Vaccines Price by Type (2017-2028) & (USD/Doses)
Figure 34. Global Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 35. Global Preventive Vaccines Revenue Market Share by Application (2017-2028)
Figure 36. Global Preventive Vaccines Price by Application (2017-2028) & (USD/Doses)
Figure 37. North America Preventive Vaccines Sales Market Share by Type (2017-2028)
Figure 38. North America Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 39. North America Preventive Vaccines Sales Market Share by Country (2017-2028)
Figure 40. North America Preventive Vaccines Revenue Market Share by Country (2017-2028)
Figure 41. United States Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Preventive Vaccines Sales Market Share by Type (2017-2028)
Figure 45. Europe Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 46. Europe Preventive Vaccines Sales Market Share by Country (2017-2028)
Figure 47. Europe Preventive Vaccines Revenue Market Share by Country (2017-2028)
Figure 48. Germany Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Preventive Vaccines Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Preventive Vaccines Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Preventive Vaccines Revenue Market Share by Region (2017-2028)
Figure 57. China Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Preventive Vaccines Sales Market Share by Type (2017-2028)
Figure 64. South America Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 65. South America Preventive Vaccines Sales Market Share by Country (2017-2028)
Figure 66. South America Preventive Vaccines Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Preventive Vaccines Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Preventive Vaccines Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Preventive Vaccines Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2021
Figure 78. Manufacturing Process Analysis of Preventive Vaccines
Figure 79. Preventive Vaccines Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
